$BBAI
BigBear.ai Holdings Inc Stock $bbai

$bbai Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000162828022022685 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$40.65M	$37.61M	$36.39M
YoY Change		3.59%	2.31%
Cost Of Revenue	$28.90M	$28.02M	$26.52M
YoY Change	-1.77%	3.22%	4.88%
Gross Profit	$11.75M	$9.590M	$9.867M
YoY Change	8.83%	4.66%	-4.02%
Gross Profit Margin	28.91%	25.5%	27.11%
Selling, General & Admin	$20.23M	$26.95M	$22.02M
YoY Change	930.08%	159.03%	117.72%
% of Gross Profit	172.18%	281.04%	223.17%
Research & Development	$1.785M	$2.535M	$2.874M
YoY Change	30.96%	35.78%	209.7%
% of Gross Profit	15.19%	26.43%	29.13%
Depreciation & Amortization	$2.038M	$1.954M	$1.772M
YoY Change
% of Gross Profit	17.34%	20.38%	17.96%
Operating Expenses	$22.02M	$29.49M	$24.89M
YoY Change	1020.95%	140.28%	125.45%
Operating Profit	-$12.40M	-$55.34M	-$16.43M
YoY Change	531.04%	1679.83%	2055.64%
Interest Expense	$3.557M	$3.554M	$3.555M
YoY Change	39203.87%	92.21%	91.13%
% of Operating Profit
Other Income/Expense, Net	-$8.000K	$26.00K	-$30.00K
YoY Change	-124.25%	-111.31%	35.62%
Pretax Income	-$15.86M	-$58.66M	-$18.75M
YoY Change	725.0%	1083.22%	615.3%
Income Tax	$252.0K	-$1.820M	$77.00K
% Of Pretax Income
Net Earnings	-$16.11M	-$56.84M	-$18.83M
YoY Change	736.93%	1690.36%	672.47%
Net Earnings / Revenue	-39.63%	-151.13%	-51.73%
Basic Earnings Per Share	-$0.13	-$0.45	-$0.14
Diluted Earnings Per Share	-$0.13	-$0.45	-$0.14
COMMON SHARES
Basic Shares Outstanding	126.3M shares	126.2M shares	131.9M shares
Diluted Shares Outstanding	126.3M shares	126.2M shares	131.9M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.96M	$29.83M	$59.98M
YoY Change	2135.17%	1706.03%	2660.21%
Cash & Equivalents	$21.96M	$29.83M	$59.98M
Short-Term Investments
Other Short-Term Assets	$5.084M	$8.097M	$6.601M
YoY Change	1362.31%	2097.64%	712.13%
Inventory
Prepaid Expenses
Receivables	$31.65M	$28.55M	$26.62M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$60.01M	$67.72M	$96.14M
YoY Change	4408.36%	3249.56%	3119.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.528M	$1.433M	$1.335M
YoY Change
Goodwill	$67.13M	$67.16M	$91.64M
YoY Change
Intangibles	$87.55M	$89.46M	$81.98M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$692.0K	$727.0K	$741.0K
YoY Change	504.42%	274.04%
Total Long-Term Assets	$156.9M	$158.8M	$175.7M
YoY Change	-56.29%	-55.77%	-51.04%
TOTAL ASSETS
Total Short-Term Assets	$60.01M	$67.72M	$96.14M
Total Long-Term Assets	$156.9M	$158.8M	$175.7M
Total Assets	$216.9M	$226.5M	$271.8M
YoY Change	-39.79%	-37.26%	-24.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.426M	$6.354M	$6.625M
YoY Change	27954.4%	18267.88%	12985.64%
Accrued Expenses	$17.49M	$15.98M	$17.04M
YoY Change	656.64%	1321.0%	4598.07%
Deferred Revenue	$4.758M	$3.714M	$2.792M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$769.0K	$1.921M	$3.074M
YoY Change
Total Short-Term Liabilities	$32.74M	$28.85M	$30.16M
YoY Change	1262.95%	2292.83%	6827.38%
LONG-TERM LIABILITIES
Long-Term Debt	$191.8M	$191.3M	$190.9M
YoY Change
Other Long-Term Liabilities	$36.00K	$136.0K	$343.0K
YoY Change	-99.72%	-98.95%	-97.31%
Total Long-Term Liabilities	$191.9M	$191.5M	$191.2M
YoY Change	1382.41%	1375.64%	1397.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.74M	$28.85M	$30.16M
Total Long-Term Liabilities	$191.9M	$191.5M	$191.2M
Total Liabilities	$225.0M	$220.7M	$221.8M
YoY Change	1366.35%	1456.36%	1579.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$223.2M	-$207.1M	-$150.2M
YoY Change		8566.08%	23086.12%
Common Stock	$272.4M	$270.2M	$257.6M
YoY Change		3556.61%	4461.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$57.35M
YoY Change
Treasury Stock Shares			9.953M shares
Shareholders Equity	-$8.099M	$5.789M	$50.05M
YoY Change
Total Liabilities & Shareholders Equity	$216.9M	$226.5M	$271.8M
YoY Change	-39.79%	-37.26%	-24.87%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$16.11M	-$56.84M	-$18.83M
YoY Change	736.93%	1690.36%	672.47%
Depreciation, Depletion And Amortization	$2.038M	$1.954M	$1.772M
YoY Change
Cash From Operating Activities	-$6.394M	-$24.47M	-$7.529M
YoY Change	855.21%	4593.28%	-943.11%
INVESTING ACTIVITIES
Capital Expenditures	-$228.0K	-$149.0K	$359.0K
YoY Change			111.18%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	-$89.00K	-$4.376M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$317.0K	-$4.525M	-$359.0K
YoY Change			-8.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$100.9M
YoY Change			-128.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.163M	-1.157M	-$102.1M
YoY Change			37010.91%
NET CHANGE
Cash From Operating Activities	-6.394M	-24.47M	-$7.529M
Cash From Investing Activities	-317.0K	-4.525M	-$359.0K
Cash From Financing Activities	-1.163M	-1.157M	-$102.1M
Net Change In Cash	-7.874M	-30.15M	-$109.9M
YoY Change	1076.31%	5683.2%	-49181.7%
FREE CASH FLOW
Cash From Operating Activities	-$6.394M	-$24.47M	-$7.529M
Capital Expenditures	-$228.0K	-$149.0K	$359.0K
Free Cash Flow	-$6.166M	-$24.32M	-$7.888M
YoY Change			-1191.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001836981
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40031
	dei	Entity Registrant Name EntityRegistrantName	BigBear.ai Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-4164597
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6811 Benjamin Franklin Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Columbia
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	21046
	dei	City Area Code CityAreaCode	410
	dei	Local Phone Number LocalPhoneNumber	312-0885
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126265764	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29829000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68900000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	101021000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	87000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	43000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28546000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28605000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1252000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	628000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8097000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7028000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	67724000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	206182000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1433000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1078000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	67164000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	91636000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	89456000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83646000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	727000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	780000	usd
CY2022Q2	us-gaap	Assets Assets	226504000	usd
CY2021Q4	us-gaap	Assets Assets	383322000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6354000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5475000	usd
CY2022Q2	us-gaap	Debt Current DebtCurrent	1921000	usd
CY2021Q4	us-gaap	Debt Current DebtCurrent	4233000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15978000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10735000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3714000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4207000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	44827000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	881000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	541000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	28848000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	70018000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	191341000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190364000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	390000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	248000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	136000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	324000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	220715000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	260954000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126263451	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126263451	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	135566227	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	14000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	270184000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	253744000	usd
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	9952803	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57350000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-207059000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-131390000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5789000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	122368000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	226504000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	383322000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37613000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36311000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74003000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71881000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	28023000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	27148000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	54546000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	52438000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	9590000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	9163000	usd
	us-gaap	Gross Profit GrossProfit	19457000	usd
	us-gaap	Gross Profit GrossProfit	19443000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26952000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10405000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48972000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20519000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2535000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1867000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5409000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2795000	usd
CY2022Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	186000	usd
CY2021Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3871000	usd
CY2021Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1585000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-55335000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3109000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-71761000	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3554000	usd
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1849000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	7109000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3709000	usd
CY2022Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	199000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1462000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	26000	usd
CY2021Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58664000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4958000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-77412000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7579000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1820000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1783000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1743000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1967000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-56844000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3175000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5612000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126223903	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129037598	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126223903	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129037598	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	50051000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-56844000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5080000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7501000	usd
CY2022Q2	bbai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5789000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	97985000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3175000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	94841000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	122368000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75669000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8938000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	57350000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7501000	usd
	bbai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5789000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	100397000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5612000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	94841000	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105000000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-75669000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5612000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3726000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3673000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1047000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	286000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8938000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	56000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	44000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1594000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1996000	usd
	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	-1462000	usd
	bbai	Fair Value Adjustments Of Warrants And Derivatives FairValueAdjustmentsOfWarrantsAndDerivatives	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-758000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1580000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	226000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-1557000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-535000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4299000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	874000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2251000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2509000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5227000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	101021000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2048000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	494000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	338000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	275000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31996000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	332000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4376000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	224000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	508000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	282000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4884000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-506000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100896000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2312000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	550000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-103212000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-550000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-140092000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-724000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169921000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9704000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29829000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8980000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	7501000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29829000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	68900000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29829000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169921000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q4	bbai	Holding Period Of Shares HoldingPeriodOfShares	P3M
CY2021Q4	bbai	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	101958000	usd
CY2021Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	17391304	shares
CY2021Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	11.50
CY2021Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	114393000	usd
CY2021Q4	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	9802000	usd
CY2021Q4	bbai	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	501000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	bbai	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	75000000	usd
CY2021Q4	bbai	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	105000000	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8000000	shares
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
CY2022Q2	bbai	Goodwill Increase In Weighted Average Cost Of Capital Percentage GoodwillIncreaseInWeightedAverageCostOfCapitalPercentage	0.01
CY2022Q2	bbai	Goodwill Reduction In Forecasted Revenues Percentage GoodwillReductionInForecastedRevenuesPercentage	0.03
CY2021Q4	us-gaap	Goodwill Goodwill	91636000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	67164000	usd
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4732000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2217000	usd
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	2099000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	4265000	usd
CY2022Q2	bbai	Pre Contract Costs PreContractCosts	1266000	usd
CY2021Q4	bbai	Pre Contract Costs PreContractCosts	546000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8097000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7028000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12876000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9011000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	597000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	842000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2505000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	882000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15978000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10735000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	201921000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	204233000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8659000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9636000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	193262000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	194597000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1921000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4233000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	191341000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	190364000	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	200000000	usd
	bbai	Operating Leases Of Lessee Renewal Term OperatingLeasesOfLesseeRenewalTerm	P5Y
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.031
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.360
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.023
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.260
CY2021Q4	bbai	Share Repurchase Obligation Liability ShareRepurchaseObligationLiability	9952803	shares
CY2022Q1	bbai	Period For Reduced Price Repurchase PeriodForReducedPriceRepurchase	P3M
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	10.125
CY2021Q4	us-gaap	Escrow Deposit EscrowDeposit	101021000	usd
	bbai	Share Repurchase Program Release Of Escrow ShareRepurchaseProgramReleaseOfEscrow	100896000	usd
	bbai	Share Repurchase Program Reclassified To Cash And Cash Equivalent ShareRepurchaseProgramReclassifiedToCashAndCashEquivalent	125000	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	44827000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1281000	usd
	bbai	Derivative Liability Settlement DerivativeLiabilitySettlement	43546000	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126263451	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	135566227	shares
	bbai	Common Stock Voting Rights Vote For Each Share CommonStockVotingRightsVoteForEachShare	1	vote
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.60
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	482000	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	9.99
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	525234	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.60
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	49665	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	9.14
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	957569	shares
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y7M6D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75669000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5080000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8938000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-56844000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-3175000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5612000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126223903	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126223903	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129037598	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129037598	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105000000	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	957569	shares
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8.18
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	18844600	shares
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	10.61
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	477280	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37613000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36311000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74003000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71881000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37613000	usd
CY2022Q2	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36311000	usd
CY2021Q2	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74003000	usd
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71881000	usd
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1252000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	628000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3714000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4207000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4207000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	130000000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.97
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37613000	usd
CY2022Q2	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	12049000	usd
CY2022Q2	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.32
CY2022Q2	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	1450000	usd
CY2022Q2	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	-1009000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26952000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2535000	usd
CY2022Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	186000	usd
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-55335000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-199000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	3554000	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	26000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-58664000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36311000	usd
CY2021Q2	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	11792000	usd
CY2021Q2	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.32
CY2021Q2	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	2629000	usd
CY2021Q2	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	0	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10405000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1867000	usd
CY2021Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3109000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4000	usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	1849000	usd
CY2021Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4958000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74003000	usd
	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	24721000	usd
	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.33
	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	3555000	usd
	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	-1709000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48972000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5409000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1585000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	35252000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-71761000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1462000	usd
	us-gaap	Interest Expense InterestExpense	7109000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-77412000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	71881000	usd
	bbai	Segment Adjusted Gross Margin SegmentAdjustedGrossMargin	24300000	usd
	bbai	Segment Adjusted Gross Profit Percentage SegmentAdjustedGrossProfitPercentage	0.34
	bbai	Research And Development Costs Excluded From Segment Adjusted Gross Margin ResearchAndDevelopmentCostsExcludedFromSegmentAdjustedGrossMargin	4857000	usd
	bbai	Equity Based Compensation Excluded From Segment Adjusted Gross Margin EquityBasedCompensationExcludedFromSegmentAdjustedGrossMargin	0	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20519000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2795000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3871000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Interest Expense InterestExpense	3709000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7579000	usd
CY2022Q2	us-gaap	Assets Assets	226504000	usd
CY2021Q4	us-gaap	Assets Assets	383322000	usd

Files In Submission

Name	View Source	Status
0001628280-22-022685-index-headers.html	Edgar Link	pending
0001628280-22-022685-index.html	Edgar Link	pending
0001628280-22-022685.txt	Edgar Link	pending
0001628280-22-022685-xbrl.zip	Edgar Link	pending
bbai-20220630.htm	Edgar Link	pending
bbai-20220630.xsd	Edgar Link	pending
exhibit101-firstamendmentt.htm	Edgar Link	pending
exhibit311-ceocertificatio.htm	Edgar Link	pending
exhibit312-cfocertificatio.htm	Edgar Link	pending
exhibit321-906ceo6302022.htm	Edgar Link	pending
exhibit322-906cfo6302022.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
bbai-20220630_def.xml	Edgar Link	unprocessable
bbai-20220630_lab.xml	Edgar Link	unprocessable
bbai-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bbai-20220630_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bbai-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBAI
BigBear.ai Holdings Inc Stock $bbai

2022 Q3 Form 10-Q Financial Statement

#000162828022022685 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI BigBear.ai Holdings Inc Stock $bbai

2022 Q3 Form 10-Q Financial Statement

#000162828022022685 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBAI
BigBear.ai Holdings Inc Stock $bbai